TAIPEI, Nov. 6, 2025 -- Senior health officials, clinicians, and policy leaders from across the Asia Pacific region convened in Taipei for the hepatocellular carcinoma (HCC) Leadership & Policy Forum, hosted by the APAC Liver Disease Alliance, the Taiwan Health Promotion Administration and the Taiwan National Health Insurance Administration. The event marked a pivotal moment in regional efforts to combat HCC, the most common type of liver cancer and a major public health challenge across the Asia-Pacific. During the Forum, the Alliance launched a peer-reviewed publication t
HONG KONG, Nov. 6, 2025 -- In the era of artificial intelligence, the rapid advancements in AI and robotics are revolutionizing healthcare — reshaping diagnosis, treatment, and health management. How to deeply integrate these cutting-edge technologies into clinical practice, and transform innovative algorithms into tangible tools to save lives, has become a global priority. On 26 October, the 3rd Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium opened at the Hong Kong Convention and Exhibition Centre. Organized by the Centre for AI and Robotics (CAIR), H
HELSINKI, Nov. 6, 2025 -- The world's leading innovation award, Millennium Technology Prize, will be awarded again in May 2027. The eligibility criteria of the prize have been expanded to even more future-oriented innovations that improve the well-being of humankind and the planet and stimulate further research and development. The global call for nominations will be open for groundbreaking innovations between 6 November 2025 and 27 February 2026. The Millennium Technology Prize is the pre-eminent one-million-euro award focused on technological innovations for a better life. The winnin
SYDNEY, Nov. 6, 2025 -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate Professor Gavin Sacks, to its medical leadership team, continuing the organisation's 40-year tradition of clinical leadership excellence. Dr Sacks brings over 20 years of experience at the forefront of reproductive medicine and is recognised globally for his groundbreaking research in reproductive medicine including luteinising hormone (LH) supplementation, innovative stimulation protocols, genomic screenin
Quarterly global cigarette revenue surpasses KRW 500 billion for the first time; cigarette& NGP performs solidly hand-in-hand Acquires ASF jointly with Altria, modern product's global expansion to gain momentum SEOUL, South Korea, Nov. 6, 2025 -- KT&G (KRX: 033780) presented its simultaneous achievement of record-high quarterly revenue and operating profit based on core business competitiveness and profitability-focused growth strategy, announcing its according upward adjustment of yearly guidance during an earnings call held on the 6th. KT&a
SHANGHAI, Nov. 5, 2025 -- The International Symposium on Myofunctional Therapy in Multidisciplinary Collaboration, hosted by the Chinese Association of Orofacial Myology (CHAOM) and supported by Smartee Denti-Technology, concluded successfully in Shanghai. The event brought together leading clinicians, educators, and researchers from China and the United States to examine the evolving role of orofacial myofunctional therapy (OMT) in contemporary orthodontic practice. OMT Gains Ground as a Critical Component of Orthodontic Diagnostics and Treatment Planning Keynote speake
HONG KONG, Nov. 6, 2025 -- On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center (Shanghai). As a "full-attendance" exhibitor for eight consecutive years, Fosun, together with its overseas member companies and global partners, is showcasing a range of world-leading innovative drugs, advanced medical devices, and achievements in international collaboration at the Fosun Pharma booth in the Medical Equipment and Healthcare Products Exhibition Area. The exhibits focus on core therapeutic areas including oncology, immun
HONG KONG, Nov. 6, 2025 -- MediTrust Health, the largest innovative healthcare payor platform in China, delivered key insights recently at the HealthTech Forum of "Hong Kong FinTech Week 2025." Seth Zhang, Founder and CEO of MediTrust Health, stated that Artificial Intelligence (AI) is bringing disruptive innovation to the traditional insurance sector, with cross-border services emerging as a new industry trend. He emphasized that the company would leverage Hong Kong as a hub for expansion into overseas markets, highlighting its successful use cases in the Greater Bay Area (GBA) as
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both primary and metastatic pancreatic tumors in humanized mouse models. The study was published in a new Brief Report in Vaccines on November 2, 2025. The peer-reviewed Brief Report details the develo
AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 -- HIGHLIGHTS Further strong market share gains, Group +375 bps and Adecco +300 bps Group revenues +3.4% yoy, and +3.0% qoq, with all GBUs improving sequentially Adecco GBU revenues +4.5% yoy; Europe returned to growth; Americas +20% yoy, APAC +9% yoy Akkodis GBU revenues -3% yoy; German turnaround progressing well LHH GBU revenues +4% yoy, led by CT +9% yoy, Ezra +59% yoy Healthy 1